Clinical Trials Directory

Trials / Sponsors / EA Pharma Co., Ltd.

EA Pharma Co., Ltd.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-ef
Healthy Volunteers
Phase 12020-01-09
CompletedA Study of E6011 in Participants With Active Crohn's Disease
Crohn's Disease
Phase 22019-04-25
CompletedA Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants
Healthy Male Participants
Phase 12019-04-22
CompletedA Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
Colitis, Ulcerative
Phase 32018-06-06
CompletedA Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administrati
Healthy Male Participants
Phase 12018-04-17
WithdrawnA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male Participants
Healthy Participants
Phase 12017-12-21
CompletedStudy to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male C
Healthy Participants
Phase 12017-07-25
TerminatedStudy of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholi
Primary Biliary Cholangitis
Phase 22017-05-29
CompletedA Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects
Healthy Male Volunteers
EARLY_Phase 12017-01-25
CompletedStudy of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis
Moderate Active Ulcerative Colitis
Phase 22016-11-28
CompletedGeneral Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
Chronic Constipation
Phase 32016-11-15
CompletedA Single Dose Study of E6130 in Japanese Healthy Adult Male Subjects
Japanese Healthy Adult Male Participants
Phase 12016-09-26
CompletedA Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease
Crohn's Disease
Phase 1 / Phase 22014-04-05